Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization
about
The mechanism of Intralipid®-mediated cardioprotection complex IV inhibition by the active metabolite, palmitoylcarnitine, generates reactive oxygen species and activates reperfusion injury salvage kinasesBeyond Preconditioning: Postconditioning as an Alternative Technique in the Prevention of Liver Ischemia-Reperfusion InjuryThe Role of Mitochondrial Reactive Oxygen Species in Cardiovascular Injury and Protective StrategiesMitochondrial reactive oxygen species: a double edged sword in ischemia/reperfusion vs preconditioningAnaesthetics as cardioprotectants: translatability and mechanismLoss of Intralipid®- but not sevoflurane-mediated cardioprotection in early type-2 diabetic hearts of fructose-fed rats: importance of ROS signalingProspects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor AgonistsConcentration-dependent wrestling between detrimental and protective effects of H2O2 during myocardial ischemia/reperfusionBradykinin and adenosine receptors mediate desflurane induced postconditioning in human myocardium: role of reactive oxygen species.Effects of sevoflurane preconditioning and postconditioning on rat myocardial stunning in ischemic reperfusion injury.Role of caveolin-3 and glucose transporter-4 in isoflurane-induced delayed cardiac protection.The polymorphic and contradictory aspects of intermittent hypoxiaSignaling epicenters: the role of caveolae and caveolins in volatile anesthetic induced cardiac protection.Sevoflurane postconditioning reduces myocardial reperfusion injury in rat isolated hearts via activation of PI3K/Akt signaling and modulation of Bcl-2 family proteinsCardioprotective Effects of Astragalin against Myocardial Ischemia/Reperfusion Injury in Isolated Rat Heart.Peroxynitrite is a key mediator of the cardioprotection afforded by ischemic postconditioning in vivoOpioid-induced preconditioning is dependent on caveolin-3 expression.Ischemia/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen speciesIsoflurane postconditioning protects against reperfusion injury by preventing mitochondrial permeability transition by an endothelial nitric oxide synthase-dependent mechanismOpioid receptors and cardioprotection - 'opioidergic conditioning' of the heartLycopene Protects against Hypoxia/Reoxygenation Injury by Alleviating ER Stress Induced Apoptosis in Neonatal Mouse Cardiomyocytes.The paradigm of postconditioning to protect the heart.In vivo cardioprotection by S-nitroso-2-mercaptopropionyl glycineCardioprotection by ischemic postconditioning during surgical procedures.Ischaemic postconditioning: from bench to bedside ...Redox balance and cardioprotection.Mechanisms of myocardial ischemia-reperfusion injury and the cytoprotective role of minocycline: scope and limitations.Overview of Experimental and Clinical Findings regarding the Neuroprotective Effects of Cerebral Ischemic Postconditioning.Delta Opioid Receptors and Cardioprotection.Catestatin reduces myocardial ischaemia/reperfusion injury: involvement of PI3K/Akt, PKCs, mitochondrial KATP channels and ROS signalling.Exendin-4 ameliorates cardiac ischemia/reperfusion injury via caveolae and caveolins-3.Intermittent hypobaric hypoxia applicability in myocardial infarction prevention and recovery.Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite.Pharmacological activation of mitochondrial BK(Ca) channels protects isolated cardiomyocytes against simulated reperfusion-induced injury.Role of Endogenous Agonists of Opioid Receptors in the Regulation of Heart Resistance to Postischemic Reperfusion Injury.Intra-cardiac remote ischemic post-conditioning attenuates ischemia-reperfusion injury in rats.Desflurane-induced and ischaemic postconditioning against myocardial infarction are mediated by Pim-1 kinase.Intermittent insulin treatment mimics ischemic postconditioning via MitoKATP channels, ROS, and RISK.Cyclosporine A at reperfusion fails to reduce infarct size in the in vivo rat heart.Sevoflurane postconditioning affects post-ischaemic myocardial mitochondrial ATP-sensitive potassium channel function and apoptosis in ageing rats.
P2860
Q21132337-E65FCC7A-E146-435F-AE33-1639C2EB3ABFQ26747244-E9564222-10BF-4410-A49A-CA8B5950E2FEQ26747310-0EB2C6B9-4E58-477B-8B4F-69B35A1CCDAEQ26861219-98BB5B22-B0DF-4CE3-B9C9-ADE4A88D02CFQ26863637-4AE8C50F-3CA1-4BD9-B369-9A1CA8E9D74DQ27314973-467BC696-96A2-4E96-AAA2-CA00737C05A3Q28066192-53C51603-47B1-4454-ACA4-3CA144A2BA02Q30669527-D5F81059-7895-4472-B1F2-92E1BBC181F2Q33644945-E1BCD2F3-6476-421F-B675-C9896FAD244AQ33781034-84B33453-DAB6-47F8-8A62-A16FDB3CD28AQ33814419-F6C1403A-97D2-4952-B8FF-4BC1E2CABFC3Q33913792-00988C83-7B25-4642-843F-A9861C28B153Q33993790-722DC8E6-AC96-4796-81E1-41507ABAC3E9Q34101786-C48D11E8-25D0-45D8-ACBD-3A7EAF6AA844Q34675305-D17F62D7-5DB6-4969-A45A-199CA3BE5186Q34855009-BF5BD290-B9D7-486B-9D83-60738E5E17D8Q34994281-90DE608D-4DC4-45F3-92C8-78E1D1EBB01DQ35113412-3AD8D1FE-F4A0-477F-97A9-EC1D5C00CE8BQ35218899-1D25255A-9D48-40FA-B738-973F45B3379BQ35286353-1A917AB2-249E-4CE4-B903-CDAFCA248A62Q35751278-94E6DC9C-988E-4C6D-B5FA-9AC33DE6B822Q37053179-0258589A-4E13-4602-8E11-C5E8AE69EE45Q37195014-126B495B-A1F1-4084-BA86-F8CE136ACD3BQ37230400-F1D6530D-C6EB-4D20-97BA-E647462F5541Q37357068-B55B742B-8C31-46CB-8D62-5158156DD419Q38155452-781BF232-5A01-46EA-85A2-0B1B2E0B9E5FQ38326656-F2B66D9D-68BA-4BEC-AB2F-6F2CA8007B1AQ38687573-D28E8B72-7E0D-4A9E-8D61-B7E8E2B88DFFQ39151222-96DAC663-C4FF-462F-9A4D-AA39C5A5508BQ39210583-C7F05EB9-793B-439A-8E90-623F75E265CFQ41852482-AF267665-9A8E-4D71-9D5B-580EE398013EQ43193972-84C721B0-D849-4062-9C03-14645A95B7A7Q43280245-F7380184-4560-4408-A3C1-7494EA85B8DAQ44047746-891A1699-1712-4FC5-AA91-4309CBE00255Q44350600-35705804-BBFD-48C8-B22B-43F4B0DDB8F8Q46057447-0D9E2C0C-5862-49B6-8500-33C09A7300D4Q46206270-13520E8F-13C2-4D4F-996B-6065C019E9B4Q46703356-C147E05C-890C-4AC8-B446-0C5485A97F6AQ47216016-EB5F9250-1BAB-41D3-9D03-51ED7FA9E84CQ47584823-0C35C49D-3A8E-4243-8A47-9A9C9382C619
P2860
Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Reactive oxygen species trigge ...... and in vitro characterization
@ast
Reactive oxygen species trigge ...... and in vitro characterization
@en
type
label
Reactive oxygen species trigge ...... and in vitro characterization
@ast
Reactive oxygen species trigge ...... and in vitro characterization
@en
prefLabel
Reactive oxygen species trigge ...... and in vitro characterization
@ast
Reactive oxygen species trigge ...... and in vitro characterization
@en
P2093
P2860
P1433
P1476
Reactive oxygen species trigge ...... and in vitro characterization
@en
P2093
David M Roth
Hemal H Patel
Takaakira Yokoyama
Yousuke Horikawa
P2860
P304
P356
10.1016/J.LFS.2007.08.031
P407
P50
P577
2007-09-09T00:00:00Z